A unique opportunity to study blood-drug interactions in real-time.

Your partner in the development of future innovative therapies.

We are a CRO offering in-house services to address important questions related to the safety and function of biopharmaceuticals.

With vast expertise in immunology and preclinical drug development, we assure high-quality immune assessments. All our services are based on Immuneed’s specially developed platform based on fresh human whole blood.

A powerful preclinical platform

Our unique platform – ID.Flow,  provides a physiologically relevant testing environment that closely mimics the blood system within the human body.

It provides multiple readouts from fresh, circulating human whole blood – making it a powerful preclinical testing method.

  1. CIRCULATION
  2. INTERACTION
  3. READOUT

A company built on a clear goal

To become the logical partner in the crucial development of future innovative therapies. By addressing important questions related to drug safety and immunology, we cut our customers’ costs and add value to drug development projects.

Insight Hub
New Podcast on Spotify

In this recent podcast, we went down memory lane and got a historical insight into how it all began, but also talked about the bright future...

Immuneed recently completed a new share issue among existing shareholders

Immuneed recently completed a new share issue among existing shareholders

Meet the team: CFO, Niklas Jaensson

We spoke to Immuneed CFO about the importance of understanding what’s behind the numbers.